rs10520873

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000264668.6(MTRR):​c.*1059T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 152,120 control chromosomes in the GnomAD database, including 4,397 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4397 hom., cov: 33)
Failed GnomAD Quality Control

Consequence

MTRR
ENST00000264668.6 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.144

Publications

15 publications found
Variant links:
Genes affected
MTRR (HGNC:7473): (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) This gene encodes a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. This protein functions in the synthesis of methionine by regenerating methionine synthase to a functional state. Because methionine synthesis requires methyl-group transfer by a folate donor, activity of the encoded enzyme is important for folate metabolism and cellular methylation. Mutations in this gene can cause homocystinuria-megaloblastic anemia, cbl E type. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
MTRR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblE
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000264668.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 5-7901117-T-C is Benign according to our data. Variant chr5-7901117-T-C is described in ClinVar as Benign. ClinVar VariationId is 354381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000264668.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRR
NM_002454.3
MANE Select
c.*1059T>C
downstream_gene
N/ANP_002445.2Q9UBK8-2
MTRR
NM_001364440.2
c.*1059T>C
downstream_gene
N/ANP_001351369.1Q9UBK8-2
MTRR
NM_001364441.2
c.*1059T>C
downstream_gene
N/ANP_001351370.1Q9UBK8-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRR
ENST00000264668.6
TSL:1
c.*1059T>C
3_prime_UTR
Exon 15 of 15ENSP00000264668.2Q9UBK8-1
MTRR
ENST00000869931.1
c.*1059T>C
splice_region
Exon 15 of 15ENSP00000539990.1
MTRR
ENST00000941611.1
c.*1059T>C
splice_region
Exon 16 of 16ENSP00000611670.1

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33318
AN:
152002
Hom.:
4399
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0794
Gnomad AMI
AF:
0.334
Gnomad AMR
AF:
0.195
Gnomad ASJ
AF:
0.217
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.337
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.218
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.219
AC:
33304
AN:
152120
Hom.:
4397
Cov.:
33
AF XY:
0.221
AC XY:
16430
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0792
AC:
3291
AN:
41540
American (AMR)
AF:
0.195
AC:
2987
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.217
AC:
752
AN:
3470
East Asian (EAS)
AF:
0.188
AC:
971
AN:
5178
South Asian (SAS)
AF:
0.238
AC:
1150
AN:
4824
European-Finnish (FIN)
AF:
0.337
AC:
3553
AN:
10536
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19785
AN:
67962
Other (OTH)
AF:
0.216
AC:
455
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1277
2555
3832
5110
6387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.255
Hom.:
6948
Bravo
AF:
0.200
Asia WGS
AF:
0.163
AC:
566
AN:
3462

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Disorders of Intracellular Cobalamin Metabolism (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
16
DANN
Benign
0.62
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10520873;
hg19: chr5-7901230;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.